# Mcneil Products · 66-41 · UNITED KINGDOM — FDA import alert red lists: firms subject to detention without physical examination

For Mcneil Products · 66-41 · UNITED KINGDOM, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is UNITED KINGDOM; product is Nicorette Nasal Spray; product code is 66 B - - 44 Nicotine Delivery System; date published is 11/03/2014; address is Maidenhead , Berkshireberkshire, UNITED KINGDOM, verified against its source on 2026-09-16.

- **Firm:** Mcneil Products _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** UNITED KINGDOM _(verified: appears in the quote below)_
- **Address:** Maidenhead , Berkshireberkshire, UNITED KINGDOM _(verified: appears in the quote below)_
- **Date published:** 11/03/2014 _(verified: appears in the quote below)_
- **Product code:** 66 B - - 44 Nicotine Delivery System _(verified: appears in the quote below)_
- **Product:** Nicorette Nasal Spray _(verified: appears in the quote below)_
- **FDA notes:** The referenced product appears to be an unapproved new drug as the product labeling lists claims such as; 'Nicorette Nasal Spray is for the rapid relief of nicotine withdrawal symptoms as an aid to giving up smoking;' 'To relieve cravings and nicotine withdrawal symptoms;' and 'You are more likely to quit smoking when using this product with help from your pharmacist; doctor; a trained counsellor or a support programme'. _(verified: appears in the quote below)_

## What the source says

> Mcneil Products Date Published : 11/03/2014 Maidenhead , Berkshireberkshire, UNITED KINGDOM 66 B - - 44 Nicotine Delivery System Date Published: 11/03/2014 Desc: Nicorette Nasal Spray Notes: The referenced product appears to be an unapproved new drug as the product labeling lists claims such as; 'Nicorette Nasal Spray is for the rapid relief of nicotine withdrawal symptoms as an aid to giving up smoking;' 'To relieve cravings and nicotine withdrawal symptoms;' and 'You are more likely to quit smoking when using this product with help from your pharmacist; doctor; a trained counsellor or a support programme'.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).